首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development in vivo
【24h】

Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development in vivo

机译:通过从壳聚糖微球中控制释放NSC23766抑制Rac1活性可有效改善体内骨关节炎的发展

获取原文
获取原文并翻译 | 示例
       

摘要

Background Osteoarthritis (OA) is a degenerative joint disease characterised by cartilage degradation and chondrocyte hypertrophy. A recent study showed that Rac1 promoted expression of MMP13 and chondrocyte hypertrophy within the growth plate. These findings warrant further investigations on the roles of Rac1 in OA development and therapy in animal models.
机译:背景技术骨关节炎(OA)是一种退行性关节疾病,其特征在于软骨退化和软骨细胞肥大。最近的一项研究表明,Rac1促进生长板中MMP13的表达和软骨细胞肥大。这些发现需要进一步研究Rac1在动物模型中对OA的发展和治疗中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号